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Objective: To determine whether women experience greater knee pain severity than men at equivalent
levels of radiographic knee osteoarthritis (OA).
Design and methods: A cross-sectional analysis of 2712 individuals (60% women) without knee
replacement or a recent steroid injection. Sex differences in pain severity at each KellgreneLawrence (KL)
grade were assessed by knee using visual analog scale (VAS) scale and Western Ontario and McMaster
Universities Arthritis Index (WOMAC) with and without adjustment for age, analgesic use, Body mass
index (BMI), clinic site, comorbid conditions, depression score, education, race, and widespread pain
(WSP) using generalized estimating equations. Effect sizes (Cohen's d) were also calculated. Analyses
were repeated in those with and without patellofemoral OA (PFOA).
Results: Women reported higher VAS pain at all KL grades in unadjusted analyses (d ¼ 0.21e0.31,
P < 0.0001e0.0038) and in analyses adjusted for all covariates except WSP (d ¼ 0.16e0.22, P < 0.0001
e0.0472). Pain severity differences further decreased with adjustment for WSP (d ¼ 0.10e0.18) and were
signiﬁcant for KL grade 2 (P ¼ 0.0015) and 2 (P ¼ 0.0200). Presence compared with absence of WSP was
associated with signiﬁcantly greater knee pain at all KL grades (d ¼ 0.32e0.52, P < 0.0001e0.0008). In
knees with PFOA, VAS pain severity sex differences were greater at each KL grade (d ¼ 0.45e0.62,
P ¼ 0.0006e0.0030) and remained signiﬁcant for all KL grades in adjusted analyses (d ¼ 0.31e0.57,
P ¼ 0.0013e0.0361). Results using WOMAC were similar.
Conclusions: Women reported greater knee pain than men regardless of KL grade, though effect sizes
were generally small. These differences increased in the presence of PFOA. The strong contribution of
WSP to sex differences in knee pain suggests that central sensitivity plays a role in these differences.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Women are at greater risk for developing knee osteoarthritis
(OA)1,2 compared with men, particularly those over 50 years of
age2.Womenwith OA have also been found to have greater levels of
knee pain and lower function3e6. However, a greater prevalence of
radiographic knee OA inwomen7,8 could account for sex differences
in knee pain and function3,4. Few studies have examined the degree
towhich the symptoms of knee OA differ betweenmen andwomen
after accounting for the degree of radiographic severity.: L.A. Frey-Law, University of
wa City, IA 52242, USA. Tel:
y-Law).
ternational. Published by Elsevier LIn addition to OA, several chronic musculoskeletal pain condi-
tions are overrepresented in women such as temporomandibular
disorders, headaches, and ﬁbromyalgia9, all of which are generally
thought to involve central sensitization. Indeed, the term, “central
sensitivity syndromes”10 has been coined to represent a number of
these frequently comorbid chronic pain conditions that may share
altered central pain processing11. The predominance of women
with central sensitivity syndrome diseases might suggest that
women are at greater risk for enhanced pain related to central
sensitization than men.
Experimental pain studies of sex differences in pain sensitivity
in healthy subjects, however, have produced somewhat inconclu-
sive results. A meta-analysis found generally greater pain sensi-
tivity in women than men for pain threshold and tolerance to atd. All rights reserved.
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d ¼ 0.09 to 0.8212. In contrast, a recent review of the literature
concluded little additional evidence is available to support clear sex
differences in acute pain sensitivity9. Others have suggested
women may be more susceptible to centrally-mediated pain than
men, since they show greater temporal summation to heat pain13
and greater referred pain in response to intramuscular experi-
mental pain14, and less conditioned pain modulation15. However,
clinical studies of knee OA have been lacking in their explicit ex-
amination of sex differences in pain sensitivity, likely in part due to
the inherently confounding issue of disease severity.
Thus, the primary purpose of this studywas to examinewhether
women exhibit greater pain than men despite similar levels of
radiographic knee OA, using a large epidemiological study of adults
with or at risk for knee OA. Our secondary aimwas to deﬁne the role
of widespread pain (WSP) in men and women, as an indication of
the presence of heightened “central sensitivity”.Methods
Study sample
For this cross-sectional analysis, data from the baseline exami-
nation of the Multicenter Osteoarthritis Study (MOST) were
utilized. MOST is an observational study that enrolled 3026
community-dwelling adults aged 50e79 years with knee OA or
known risk factors for knee OA including age, female sex, over-
weight, and history of knee symptoms, knee injury and/or surgery.
Participants were from Iowa City, IA, and Birmingham, AL or the
surrounding communities. The study design and participant eligi-
bility has been described previously16. Participants who had a
steroid injection in the past year or with a history of total knee
replacement were excluded from this study (Fig. 1). The MOST
study was approved by the institutional review boards at the Uni-
versity of Iowa; University of Alabama, Birmingham; University ofFig. 1. Participant inclusion diagram.California, San Francisco; and Boston University Medical Center. All
participants provided written, informed consent.
Assessments
Analgesic use
Participants provided information on analgesic medication
(salicylate, non-steroidal anti-inﬂammatory drug (NSAID), opioid
and “other” analgesic that included acetaminophen and other an-
algesics and antipyretics) use through an interviewer-administered
questionnaire at the clinic visit. Participants were asked whether
medications were used on an intermittent or regular basis. Ana-
lyses controlled for regular use of analgesic medications.
Anthropometric measures
Body mass index (BMI, kg/m2) was calculated from weight in
kilograms divided by the square of the height in meters (Stadi-
ometer, Holtain, Wales, UK), as measured by trained and certiﬁed
staff at the clinic visit.
Comorbid conditions
Participants completed the Charlson Comorbidity Index, a vali-
dated classiﬁcation system of comorbid conditions17. Responses
were categorized as none, one, and two or more comorbid
conditions.
Depressive symptoms score
The Center for Epidemiologic Studies Depression Scale (CES-D)18
was utilized as an indicator of depressive symptoms. The instru-
ment includes 20 items which query participants' feelings over the
past 7 days. A score of 16 or greater has been used as an indicator of
depression19.
Education
Participants provided information on the highest grade or year
of school completed. Responses were categorized into one of three
categories: less than high school education, completion of high
school and at least some college.
Knee radiographs
Weight-bearing, ﬁxed-ﬂexion posteroanterior and lateral ra-
diographs of the knees were obtained at baseline according to the
MOST radiograph protocol as previously described20. Each partici-
pant's radiographs were scored by two independent readers (an
experienced academically-based musculoskeletal radiologist and a
rheumatologist experienced in study reading) according to Kell-
greneLawrence (KL) scale at the tibiofemoral joint. Participants
who attended both the baseline MOST visit and a follow-up visit
had their baseline radiographs evaluated for the presence of
patellofemoral (PF) OA. Their PFOA status was indicated as present
if there was an osteophyte grade  2 or if there was an osteophyte
grade  1 plus presence of PF joint space narrowing (JSN)  2 or
sclerosis  2 or cysts  221.
Pain
We used two assessments to characterize knee-speciﬁc pain.
Average knee pain over the past 30 days was assessed on a
0e100 mm visual analog scale (VAS), with anchors of 0 indicating
‘no pain’ and 100 indicating ‘pain as bad as it could be’ for each
knee. Pain during activities (i.e., walking, standing, stairs) was
assessed using a subset of questions from the Western Ontario and
McMaster Universities Arthritis Index (WOMAC pain) for each knee.
This subscale comprises ﬁve items with responses that range from
no (0) to extreme (4) pain with a possible total score of 20. Higher
scores on the WOMAC indicate greater pain. WOMAC scores were
Table I
Characteristics of women compared with men (mean ± SD or % as indicated)
Characteristic Women (n ¼ 1618) Men (n ¼ 1094) P-value
Age at baseline (years) 62.3 ± 7.9 62.0 ± 8.3 0.48
BMI (kg/m2) 30.6 ± 6.3 30.4 ± 5.1 0.27
Race (% Caucasian) 83.7% 85.3% 0.26
Education (% > high school) 41.2% 50.9% <0.0001
Site (% University of Iowa) 51.5% 49.8% 0.38
WSP % 56.2% 40.4% <0.0001
CES-D score  16 (%) 13.5% 7.9% <0.0001
Comorbidities (%  1 reported) 12.2% 13.2% 0.39
Bilateral knee OA (%) 29.2% 22.3% <0.0001
PFOA (%) 22.2% 18.0% 0.0089
Salicylate use (%) 34.5% 46.7% <0.0001
NSAID use (%) 25.0% 17.3% <0.0001
Opioid use (%) 3.5% 2.7% 0.29
Other analgesic use (%) 8.8% 4.9% 0.0001
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Fig. 2. Frequency of knees by KL grade in women and men.
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severity between men and women were evaluated according to
effect sizes as well as whether differences were clinically important
(minimal clinically important differences (MCID)). The MCID uti-
lized in this studywas a difference of6% of themaximal score22,23.
This corresponded to six points for VAS and rescaled WOMAC pain.
WSP
WSP was ascertained using a homunculus. It was deﬁned using
American College of Rheumatology 1990 classiﬁcation criteria24.
WSP was considered present if participants reported pain in all ﬁve
regions of the body including axial pain, pain both above and below
the waist and pain on both the right and left sides of the body.
Statistical methods
Participant characteristics were summarized with frequencies
and means for both the eligible study cohort and those excluded.
Comparisons between men and women as well as between the
eligible and excluded participants for each covariate were assessed
using t-tests for continuous and chi-square tests for categorical
variables.
Histograms of knee pain severity and results of normality tests
(ShapiroeWilk, KolmogoroveSmirnov) revealed knee pain severity
did not follow a normal distribution. The knee was the basic unit of
analysis with each participant providing two knees. Knee-speciﬁc
pain assessments were compared between men and women us-
ing generalized estimating equations to control for the covariance
between knees in the same subject and stratiﬁed by the radio-
graphic severity of each knee: KL grade <2, 2, 3, and 4. This method
may also be used on data that are clustered and do not follow a
normal distribution. Differences in knee pain severity were
compared between men and women with the following models:
Model (1) unadjusted estimate; Model (2) adjusted for age,
BMI (kg/m2), comorbidities (none, one, two or more), CES-D score,
clinic site, educational level, frequent use of pain medications, and
race; Model (3) Model 2 further adjusted for the presence of WSP.
All analyses were adjusted for KL grade of the contralateral knee.
We also examined whether PFOA status had an impact on sex dif-
ferences in pain severity in sub-analyses. These analyses were
conducted separately because the severity of PFOAwas not graded.
PFOA was deﬁned as present or absent. All except for 376 knees
from eligible participants met criteria for evaluation of PFOA status.
The same analyses (Model 1, Model 2 and Model 3) were repeated
in knees with and without PFOA separately. Adjusted and unad-
justed least square (LS) means, 95% conﬁdence intervals (CIs) and
Standard Error (SE) for all analyses and standardized effect sizes
(Cohen's d, positive ¼ greater pain in women) were computed.
Effect sizes were deﬁned as small (d ¼ 0.2), medium (d ¼ 0.5) or
large (d ¼ 0.8)25.
LS means are deﬁned as the linear combination of the estimated
effects from a linear model. Analyses were completed using the
statistical software SAS Version 9.3 (SAS Institute Inc., Cary, NC) and
signiﬁcance was set at an alpha level of 0.05 throughout.
Results
A total of 2712 subjects (5424 knees) were included in the
current study (Fig. 1). The proportion of men and women did not
signiﬁcantly differ between those excluded due to knee replace-
ment surgery, steroid injection in the past year or missing pain or
covariate data (n¼ 314) and those included. However, the excluded
cohort tended to be slightly older (mean ± SD: 65.3 ± 7.9 vs
62.2 ± 8.1 years, P < 0.0001), have a slightly higher BMI (32.5 ± 6.6
vs 30.5 ± 5.9 kg/m2, P < 0.0001), more comorbid conditions (20.1%vs 12.6% with 2 comorbid conditions, P < 0.0001), had a greater
percentage with WSP (55.1% vs 49.9%, P < 0.0001), and less edu-
cation (35.0% vs 45.1% with  high school education, P ¼ 0.0006)
than those included.
Within the included study cohort, more women than men re-
ported depressive symptoms, WSP, and had bilateral radiographic
knee OA and PFOA (Table I). Analgesic medication use differed
between men and women with a greater percentage of men
reporting frequent salicylate analgesic use and a greater percentage
of women used NSAIDs (Table I). The distribution of men and
women with knees at each KL grade was signiﬁcantly different
(P < 0.0001) with a higher proportion of women's knees with
radiographic knee OA (40.0% KL  2) than men (34.8% KL  2),
particularly with KL grade ¼ 2 (Fig. 2, 17.6% vs 12.8%). There were
376 out of the eligible 5424 knees (6.9% of eligible knees) missing
information about PFOA status. Participants not missing PFOA data
were similar in characteristics to those included in the primary
analyses. For example, there were no signiﬁcant differences in age,
BMI, percent with bilateral knee OA, percent with at least two co-
morbid conditions, percent with a CES-D score indicating depres-
sive symptoms, percent with a level of education greater than high
school, percent with frequent medication use, percent with WSP or
percent women.
For those missing PFOA information compared with those not
missing PFOA information, age and percent women did not
signiﬁcantly differ, BMI was slightly greater (mean ± SD: 31.4 ± 6.2
vs 30.5 ± 5.8, P ¼ 0.0380), percent with WSP was greater (58.8% vs
55.1%, P ¼ 0.0110) and percent with more than a high school edu-
cation was lower (36.4% vs 45.7%, P ¼ 0.0447).
Table II
Estimated differences (LS mean ± SE, 95% CI, P-value) in pain levels in knees between women and men by KL grade
KL grade Unadjusted* Adjustedy Adjustedz
VAS pain (0e100)
KL < 2 (n ¼ 3365) 4.2 ± 0.7 (2.8e5.7) <0.0001 3.3 ± 0.7 (1.9e4.6) <0.0001 2.1 ± 0.7 (0.8e3.5) 0.0015
KL ¼ 2 (n ¼ 852) 5.3 ± 1.6 (2.1e8.5) 0.0015 4.6 ± 1.5 (1.6e7.6) 0.0036 3.5 ± 1.5 (0.6e6.4) 0.0200
KL ¼ 3 (n ¼ 838) 6.4 ± 1.8 (2.9e10.0) 0.0004 4.2 ± 1.7 (0.8e7.5) 0.0151 3.2 ± 1.7 (0.1e6.6) 0.0566
KL ¼ 4 (n ¼ 369) 7.6 ± 2.6 (2.5e12.7) 0.0038 5.0 ± 2.5 (0.1e9.9) 0.0472 4.4 ± 2.5 (0.5e9.3) 0.0792
WOMAC pain (0e100%)
KL < 2 (n ¼ 3365) 3.6 ± 0.6 (2.3e4.9) <0.0001 2.6 ± 0.6 (1.4e3.7) <0.0001 1.5 ± 0.6 (0.3e2.6) 0.0115
KL ¼ 2 (n ¼ 852) 4.8 ± 1.4 (2.1e7.5) 0.0007 4.2 ± 1.3 (1.6e6.7) 0.0016 3.1 ± 1.2 (0.7e5.6) 0.0128
KL ¼ 3 (n ¼ 838) 6.0 ± 1.5 (3.0e9.1) 0.0001 3.9 ± 1.4 (1.1e6.7) 0.0059 2.8 ± 1.4 (0.1e5.6) 0.0436
KL ¼ 4 (n ¼ 369) 3.9 ± 2.1 (0.1e8.0) 0.0605 1.3 ± 1.9 (2.5e5.1) 0.4932 0.8 ± 2.0 (3.0e4.7) 0.6699
* Adjusted for contralateral knee KL grade.
y Adjusted for age, BMI, depression score, education, clinic site, race, comorbid conditions and analgesic medication use.
z Further adjusted for presence of WSP.
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Women consistently reported greater or equal knee pain
compared with men at each KL grade as shown in Table II. In un-
adjusted analyses (Model 1), pain was greater in women than men
at each KL grade, but only clinically signiﬁcant for KL grades3. The
associated effect sizes for differences were small and ranged from
0.2 (KL grades 2) to 0.3 (KL grades 3). After adjusting for cova-
riates (Model 2), sex differences in VAS pain remained signiﬁcantly
higher in women than in men for all KL grades. In addition,
adjustment for WSP (Model 3) reduced the differences in pain
levels between men and women such that differences only
remained signiﬁcant for KL grades 2. At all KL grades, presence of
WSP (Model 3) was associated with greater pain severity with
mean VAS pain scores 7.5e10.7 higher than in those without WSP
(P < 0.0001 for KL grades <2e3 and P ¼ 0.0008 for KL grade 4).
There was a signiﬁcant interaction between sex and presence of
WSP (3.0± 1.4, 95% CI¼ 0.3e5.6, P¼ 0.0288) such that pain severity
was signiﬁcantly greater in women with WSP compared with men
with WSP.
WOMAC pain
Analyses repeated using WOMAC pain were similar to those
using VAS pain (Table II). However, in unadjusted (Model 1) and
adjusted analyses (model 2), differences in pain severity were not
statistically or clinically signiﬁcant for KL grade 4.
Subanalyses in knees with PFOA data
In knees with PFOA, women reported pain of greater severity for
all KL grades in unadjusted analyses (Model 1) for VAS pain and forTable III
Estimated differences (LS mean ± SE, 95% CI, P-value) in VAS pain levels (0e100) betwee
KL grade Unadjusted* Adjuste
þ PFOA
KL < 2 (n ¼ 160) 9.2 ± 2.9 (3.6e14.8) 0.0025 8.9 ±
KL ¼ 2 (n ¼ 248) 12.2 ± 3.1 (6.1e18.4) 0.0006 15.1 ±
KL ¼ 3 (n ¼ 238) 10.8 ± 3.3 (4.4e17.3) 0.0018 8.3 ±
KL ¼ 4 (n ¼ 179) 11.4 ± 3.7 (4.2e18.6) 0.0030 8.9 ±
¡ PFOA
KL < 2 (n ¼ 3205) 3.9 ± 0.7 (2.5e5.4) <0.0001 3.0 ±
KL ¼ 2 (n ¼ 604) 3.0 ± 1.9 (0.6e6.7) 0.1072 1.9 ±
KL ¼ 3 (n ¼ 600) 5.2 ± 2.1 (1.1e9.3) 0.0144 2.5 ±
KL ¼ 4 (n ¼ 190) 5.3 ± 3.5 (1.6e12.2) 0.1383 2.4 ±
* Adjusted for contralateral knee KL grade and PFOA status.
y Adjusted for age, BMI, depression score, education, clinic site, race, comorbid condit
z Further adjusted for presence of WSP.all KL grades <4 for WOMAC pain. Adjusted models (Models 2 and
3) slightly reduced the estimated differences though they remained
statistically signiﬁcant for all KL grades for VAS pain (Table III) and
all KL grades <4 for WOMAC pain (Table IV). In most cases, statis-
tically signiﬁcant differences also met or exceeded clinically
important differences. Effect sizes for unadjusted analyses of PFOA
were much higher than for the analyses of TFOA data. For VAS pain,
effect sizes were moderate (KL grades <2 and 4 ¼ 0.5 and KL grade
2 ¼ 0.6) or small (KL grade 3 ¼ 0.4). For WOMAC pain, effect sizes
were also moderate (KL grades 2 and 3 ¼ 0.5) or small
(KL grade<2 ¼ 0.4, KL grade 4 ¼ 0.3).
In knees without PFOA, however, statistically signiﬁcant differ-
ences were only present in knees with a KL grade <2, KL grade ¼ 2
(WOMAC only) or KL grade¼ 3 in unadjusted analyses (Model 1). In
adjusted analyses (Models 2 and 3), differences remained statisti-
cally signiﬁcant for KL grade <2 (i.e., no evidence of radiographic
TFOA or PFOA). Sex differences in VAS pain scores for knees without
PFOA are shown in Table III by KL grade while differences in
WOMAC pain are shown in Table IV. In all cases, where statistically
signiﬁcant, differences among knees without PFOA were small and
did not meet the cut-offs for clinical signiﬁcance. In addition, all
effect sizes were 0.2.
Discussion
The main results of this study showed that women generally
reported greater pain at all KL grades compared with men, espe-
cially in the presence of PFOA. These sex differences also were
found prior to the onset of radiographic knee OA (TFOA KL grade
<2) and were present regardless of adjustment for covariates in
knees without PF or TFOA. Indeed, Maleki-Fischbach and Jordan26
suggested that more studies need to speciﬁcally examine sexn women and men by KL grade in knees with PFOA and without PFOA
dy Adjustedz
3.0 (3.1e14.7) 0.0048 7.1 ± 2.9 (1.5e12.7) 0.0184
3.0 (9.2e21.1) <0.0001 11.5 ± 3.2 (5.2e17.8) 0.0013
3.1 (2.2e14.4) 0.0085 7.0 ± 3.1 (1.0e13.0) 0.0251
3.6 (1.9e16.0) 0.0165 8.0 ± 3.7 (0.7e15.3) 0.0361
0.7 (1.6e4.3) <0.0001 1.9 ± 0.7 (0.5e3.2) 0.0062
1.7 (1.5e5.3) 0.2868 1.5 ± 1.7 (1.8e4.8) 0.3725
2.0 (1.4e6.4) 0.2021 1.8 ± 2.0 (2.1e5.7) 0.3621
3.2 (4.0e8.6) 0.4727 1.8 ± 3.1 (4.3e7.9) 0.5619
ions and analgesic medication use.
Table IV
Estimated differences (LS mean ± SE, 95% CI, P-value) in WOMAC pain levels (0e100%) between women and men by KL grade in knees with PFOA and without PFOA
KL grade Unadjusted* Adjustedy Adjustedz
þ PFOA
KL < 2 (n ¼ 160) 6.2 ± 2.6 (1.2e11.2) 0.0185 5.3 ± 2.5 (0.4e10.1) 0.0408 3.9 ± 2.5 (0.9e8.7) 0.1282
KL ¼ 2 (n ¼ 248) 9.3 ± 2.7 (4.1e14.6) 0.0019 12.3 ± 2.5 (7.5e17.2) <0.0001 8.9 ± 2.6 (3.8e14.0) 0.0019
KL ¼ 3 (n ¼ 238) 9.8 ± 2.9 (4.2e15.4) 0.0013 7.6 ± 2.8 (2.2e13.0) 0.0075 6.3 ± 2.8 (0.9e11.7) 0.0269
KL ¼ 4 (n ¼ 179) 5.2 ± 2.7 (0.01e10.4) 0.0537 3.5 ± 2.5 (1.5e8.4) 0.1808 2.8 ± 2.7 (2.4e8.0) 0.3026
¡ PFOA
KL < 2 (n ¼ 3205) 3.5 ± 0.7 (2.2e4.7) <0.0001 2.4 ± 0.6 (1.2e3.6) <0.0001 1.4 ± 0.6 (0.2e2.5) 0.0214
KL ¼ 2 (n ¼ 604) 3.1 ± 1.6 (0.05e6.2) 0.0484 1.9 ± 1.5 (1.0e4.8) 0.2086 1.5 ± 1.4 (1.3e4.3) 0.2868
KL ¼ 3 (n ¼ 600) 4.9 ± 1.8 (1.4e8.4) 0.0064 2.4 ± 1.6 (0.7e5.6) 0.1384 1.4 ± 1.6 (1.7e4.5) 0.3681
KL ¼ 4 (n ¼ 190) 3.2 ± 2.8 (2.4e8.7) 0.2716 0.5 ± 2.6 (4.6e5.6) 0.8460 0.1 ± 2.5 (4.9e5.0) 0.9836
* Adjusted for contralateral knee KL grade and PFOA status.
y Adjusted for age, BMI, depression score, education, clinic site, race, comorbid conditions and analgesic medication use.
z Further adjusted for presence of WSP.
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for OA act similarly in both men and women, rather than simply
controlling for sex.
Our results are consistent with previous ﬁndings. In one large
cohort study, a greater proportion of women had symptomatic
knee OA than men, when stratifying by knee OA grade27. Similarly,
in a Korean population, symptom severity was greater in women
compared with men at the same KL grade, with the exception of KL
grade 328. However, that particular KL grade comparison was likely
underpowered. In a study conducted in the Netherlands, Schiphof
et al. found being female was a signiﬁcant risk factor for knee pain,
but the increased risk for women was not KL grade speciﬁc29. In a
study involving adults scheduled for knee replacement surgery,
women were found to have greater pain intensity during move-
ment and pain sensitivity compared with men6. Lastly, in a study of
older adults with knee pain, men were found to have a higher
incidence of radiographic disease30, suggesting women had similar
pain despite less severe disease. Our ﬁndings further expand on
these previous studies by considering PFOA and covariates thatmay
account for sex differences, radiographic status of the contralateral
knee, and study of a larger sample size. While gender-related pain
changes have been observed when considering either TFOA or
PFOA, few studies have attempted to consider both variables in the
same study. Thus, in addition to the large sample size, this study
uniquely considered the presence of PFOA in addition to KL grade
when evaluating sex differences.
Results from the main analyses in our study in knees with
radiographic TFOA showed that sex differences in knee pain
severity were largely explained by BMI, depressive symptoms, co-
morbid conditions, socioeconomic status, and, especially, presence
of WSP. However, signiﬁcant differences generally remained
following adjustment for all covariates for KL grades <4, suggesting
additional unmeasured factors may contribute to knee pain
severity differences between men and women at these particular
grades. For example, KL grade 2 corresponds with presence of
osteophytes while KL grade 3 corresponds with the onset of JSN
whichwas found to have a stronger associationwith knee pain than
osteophytes in a large cohort study31. Though not detectable by
radiography, JSN may reﬂect loss of cartilage as well as features
associated with knee pain such as meniscal extrusion32,33. How-
ever, we found estimates for differences in knee pain severity be-
tween women and men were slightly lower for KL grade 3 than for
KL grade 2. In our study, sex differences were typically the least
pronounced at the highest KL grade (KL grade 4). In those cases, the
underlying nociceptive input from the damaged knees may over-
ride other factors contributing to the heterogeneous pain experi-
ence, such as multiple psychosocial, experimental, genetic, and
neurochemical variables that can inﬂuence sex differences in both
clinical and experimental pain perception34.The largest differences we observed for pain severity were in
knees with PFOA. This is consistent with previous data that show
PFOA is an important contributor to knee pain35,36. It has also been
suggested that risk factors for TFOA and PFOAmay differ37,38, which
could explain why WSP had a more signiﬁcant effect on pain
severity differences between men and women with TFOA than in
knees with both PFOA and TFOA. Thus, our ﬁndings support eval-
uation of the PF joint in addition to the more commonly evaluated
TF joint in studies of knee OA and knee pain.
The reasons for the sex differences in knee OA and knee OA
symptoms have yet to be fully elucidated. It has been suggested
that sex differences in hormones, body composition, psychosocial
characteristics, knee structure and neural processing may play a
role. Several studies have examined the role of estrogens on knee
OA. While results support a contribution to knee OA39e41, the
evidence is not deﬁnitive. BMI has been found to be highly pre-
dictive of both knee OA42,43 and knee pain44 and, similar to our
study, BMI is generally greater in women than in men. Psycho-
social characteristics such as depression may also contribute. For
example, it has been reported that women have higher rates of
depression45, which has also been associated with pain46. In
addition, structural differences between men and women,
including cartilage thickness, volume, and joint surface area have
been documented47e49.
The evidence for the role of central sensitization in various pain
conditions is growing. While WSP is not a measure of central
sensitivity, it is believed to involve centrally-mediated processes50.
Our hypothesis, that presence of WSP would be associated with
greater knee pain for each radiographic knee OA severity level was
supported. We also found a higher proportion of women than men
with some degree of WSP at baseline. Since women may be more
susceptible to centrally-mediated pain than men13e15, a proportion
of the observed sex differences in those with OA could be a result of
centrally-mediated mechanisms. However, presence of WSP did
not appear to explain sex differences in pain severity in knees with
PFOA.
Our ﬁndings should be interpreted in light of the following
limitations. First, we categorized individuals by radiographic
tibiofemoral KL grades and presence/absence of PFOA, though
these grades cannot fully represent differences in peripheral joint
disease, such as synovitis or other pathologies, that may further
contribute to sex differences. In addition, categorization of knees
by presence or absence of PFOA was less precise than grading
structural changes at the PF joint and it is possible that women
may have had more severe PFOA than men in our study, but this
could not be determined from the available data. Despite our less
precise assessment of the PF joint, we found differences in pain
severity between men and women with PFOA were clinically
signiﬁcant for all KL grades for VAS pain and all KL grades <4 for
N. Glass et al. / Osteoarthritis and Cartilage 22 (2014) 1100e1106 1105WOMAC pain. We found the magnitude of the sex-differences in
pain, though signiﬁcant, to be relatively small for TFOA. In
particular, these differences required relatively large sample sizes
to be adequately powered, especially for knees with KL grades <2.
This is likely one of the reasons this issue has not been well
characterized in previous studies. Lastly, this analysis evaluated
sex differences in knee pain, controlling for radiographic severity,
but did not include measures of central sensitization. Future
studies further examining whether these observed sex differences
could be explained by sex differences in central pain modulation
would be desirable. However, this information advances our
general understanding of sex differences in knee pain due to OA,
which may assist in the care of individual patients despite the
relatively small overall mean effect size. That is, numerous factors
likely contribute to pain variability, but greater pain in women,
even after controlling for numerous confounding variables, was
consistently observed.
In summary, women report greater knee pain than men despite
similar levels of radiographic knee OA. Thus, a disparity in disease
impact for knee OA between men and women was observed, and
exists prior to the onset of radiographic knee OA. However, sex
differences were in part ameliorated by considering the presence of
PF knee OA; supporting that the PF joint, in addition to the TF joint,
should be included in future studies of knee pain. The strong as-
sociation between pain severity and presence of WSP suggests that
central sensitivity may be one component contributing to the
observed sex differences.
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